Pharmaceutical

Fujitsu tackles ‘drug loss’ in Japan through ecosystem to accelerate digitalization of clinical trials

Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI TOKYO, Aug. 26, 2024…

1 year ago

TraceLink Becomes First Solution Provider to Secure All 16 GS1 US Conformance Trustmarks for EPCIS File Support

BOSTON, Aug. 26, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences…

1 year ago

World-Renowned Scientist Wah Chiu, Stanford University Professor and Honorary Advisor to Pohang City, visited Korea at the invitation of the Coree Group

- Seminar presentation at the invitation of Dx&Vx and Coree Group SEOUL, South Korea, Aug. 26, 2024 /PRNewswire/ -- Professor Wah…

1 year ago

GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024

CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide…

1 year ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

BOULDER, CO / ACCESSWIRE / August 26, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

1 year ago

MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study

Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIAMI, FL / ACCESSWIRE / August…

1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

FORT LAUDERDALE, FL / ACCESSWIRE / August 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering…

1 year ago

MPOX is Emerging as a Global Threat – NanoViricides Investigating MEURI Protocol for Using NV-387 to Treat MPOX

SHELTON, CT / ACCESSWIRE / August 26, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…

1 year ago

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

PASADENA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”),…

1 year ago